chr14-57391360-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001011713.3(NAA30):c.403G>A(p.Gly135Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000354 in 1,611,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001011713.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAA30 | NM_001011713.3 | c.403G>A | p.Gly135Ser | missense_variant | 2/5 | ENST00000556492.6 | NP_001011713.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAA30 | ENST00000556492.6 | c.403G>A | p.Gly135Ser | missense_variant | 2/5 | 1 | NM_001011713.3 | ENSP00000452521.1 | ||
NAA30 | ENST00000298406.6 | c.58G>A | p.Gly20Ser | missense_variant | 1/4 | 1 | ENSP00000298406.6 | |||
NAA30 | ENST00000554703.1 | c.-4+655G>A | intron_variant | 1 | ENSP00000451255.1 | |||||
NAA30 | ENST00000555166.5 | c.-4+655G>A | intron_variant | 2 | ENSP00000450939.1 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152262Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000249 AC: 6AN: 240754Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 131778
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1459364Hom.: 0 Cov.: 31 AF XY: 0.0000152 AC XY: 11AN XY: 725956
GnomAD4 genome AF: 0.000190 AC: 29AN: 152380Hom.: 0 Cov.: 33 AF XY: 0.000201 AC XY: 15AN XY: 74518
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2023 | The c.403G>A (p.G135S) alteration is located in exon 2 (coding exon 1) of the NAA30 gene. This alteration results from a G to A substitution at nucleotide position 403, causing the glycine (G) at amino acid position 135 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at